Paul Scherrer Institut, 5232 Villigen PSI, Switzerland.
Nature. 2011 Mar 31;471(7340):656-60. doi: 10.1038/nature09795. Epub 2011 Mar 9.
G-protein-coupled receptors (GPCRs) comprise the largest family of membrane proteins in the human genome and mediate cellular responses to an extensive array of hormones, neurotransmitters and sensory stimuli. Although some crystal structures have been determined for GPCRs, most are for modified forms, showing little basal activity, and are bound to inverse agonists or antagonists. Consequently, these structures correspond to receptors in their inactive states. The visual pigment rhodopsin is the only GPCR for which structures exist that are thought to be in the active state. However, these structures are for the apoprotein, or opsin, form that does not contain the agonist all-trans retinal. Here we present a crystal structure at a resolution of 3 Å for the constitutively active rhodopsin mutant Glu 113 Gln in complex with a peptide derived from the carboxy terminus of the α-subunit of the G protein transducin. The protein is in an active conformation that retains retinal in the binding pocket after photoactivation. Comparison with the structure of ground-state rhodopsin suggests how translocation of the retinal β-ionone ring leads to a rotation of transmembrane helix 6, which is the critical conformational change on activation. A key feature of this conformational change is a reorganization of water-mediated hydrogen-bond networks between the retinal-binding pocket and three of the most conserved GPCR sequence motifs. We thus show how an agonist ligand can activate its GPCR.
G 蛋白偶联受体 (GPCRs) 是人类基因组中最大的膜蛋白家族,介导细胞对广泛的激素、神经递质和感觉刺激的反应。尽管已经确定了一些 GPCR 的晶体结构,但大多数都是经过修饰的形式,显示出很少的基础活性,并与反向激动剂或拮抗剂结合。因此,这些结构对应于非活性状态的受体。视觉色素视紫红质是唯一存在被认为处于活性状态的结构的 GPCR。然而,这些结构是针对无激动剂全反式视黄醛的无蛋白(或视蛋白)形式。在这里,我们展示了一个分辨率为 3 Å 的晶体结构,用于与来自 G 蛋白转导子 α 亚基羧基末端的肽结合的组成型活性视紫红质突变体 Glu113Gln。该蛋白处于活性构象,在光激活后保留视黄醛在结合口袋中。与基态视紫红质的结构比较表明,视黄醛 β-异戊二烯环的移位如何导致跨膜螺旋 6 的旋转,这是激活的关键构象变化。这种构象变化的一个关键特征是视网膜结合口袋和三个最保守的 GPCR 序列基序之间水介导氢键网络的重新组织。因此,我们展示了激动剂配体如何激活其 GPCR。